Butalbital - Prices & Where to Buy
- What butalbital is and how it is classified
- How it works (GABA mechanism as a barbiturate)
- Its role in combination medications (Fioricet, Esgic)
- Common and serious side effects
- Dependence potential and withdrawal risks
- Drug interactions and contraindications
- Precautions and when to contact a clinician
- Personalized medical advice or treatment recommendations
- Specific dosing for your individual condition
- Information about purchasing medications
- Alternatives to prescribed treatments (consult your provider)
Page Contents
What Is Butalbital?
Butalbital is a short- to intermediate-acting barbiturate that belongs to the sedative-hypnotic class of medications. It is primarily used as a component of combination medications, most notably Fioricet (butalbital/acetaminophen/caffeine) and Esgic (butalbital/acetaminophen/caffeine).
Butalbital was first developed in the 1940s and has been used in various combination products for decades. It is not typically prescribed as a standalone medication but is formulated with acetaminophen and caffeine to provide comprehensive relief for tension headaches.
While butalbital itself is not classified as a controlled substance under federal law, it is a barbiturate with recognized abuse and dependence potential. Some states may have additional regulatory requirements.
How Butalbital Works
Butalbital works by binding to the GABA-A receptor at the barbiturate binding site, which is distinct from the benzodiazepine binding site. This binding increases the duration of chloride channel opening in response to GABA, enhancing inhibitory neurotransmission.
The enhanced GABA activity produces:
- Sedation and hypnosis — reduction in anxiety and promotion of sleep
- Muscle relaxation — reduction in skeletal muscle tension, which contributes to tension headache relief
- Anxiolytic effects — reduction in anxiety that can accompany tension headaches
- Anticonvulsant effects — though this is not the primary therapeutic use of butalbital in combination products
The combination with acetaminophen provides direct pain relief (analgesia), while caffeine enhances the analgesic effect and promotes vasoconstriction. Together, these three components address multiple aspects of tension headaches.
Classification & Schedule
| Drug Name | Butalbital |
|---|---|
| Drug Class | Barbiturate (short- to intermediate-acting) |
| DEA Schedule | Not a federally controlled substance (butalbital has abuse potential; some states regulate barbiturates) |
| Prescription Required | Yes (in combination products) |
| Availability | In combination products only (Fioricet, Esgic, generic equivalents) |
| Half-life | 35-40 hours (intermediate-acting) |
Uses
Butalbital is used exclusively in combination products for the treatment of tension headaches. It is not prescribed as a standalone medication.
- Fioricet (butalbital 50 mg / acetaminophen 300-325 mg / caffeine 40 mg): Most commonly prescribed combination for tension headaches
- Esgic (butalbital 50 mg / acetaminophen 325 mg / caffeine 40 mg): Similar formulation
- Generic equivalents: Multiple manufacturers produce generic butalbital combination products
Butalbital's muscle-relaxant and sedative properties address the muscle tension and stress components of tension headaches, while acetaminophen provides analgesia and caffeine enhances the pain-relieving effect.
Butalbital-containing combinations are generally recommended for short-term, intermittent use due to the risk of medication overuse headache and dependence.
Side Effects
Common Side Effects
These are the most frequently reported side effects of butalbital-containing medications:
- Drowsiness and sedation — the most common side effect; avoid driving or operating machinery
- Dizziness and lightheadedness
- Confusion — especially at higher doses or in elderly patients
- Nausea and vomiting
- Abdominal pain
- Dry mouth
- Insomnia — paradoxically, due to caffeine content in combination products
- Feeling intoxicated
- Mental fogginess
Serious Side Effects
Contact your healthcare provider or seek emergency medical attention if you experience:
- Severe allergic reaction (anaphylaxis) — hives, difficulty breathing, swelling of face/throat
- Severe respiratory depression — slow or difficult breathing, especially when combined with opioids or other CNS depressants
- Severe drowsiness or unresponsiveness
- Liver damage — from acetaminophen component (right upper abdominal pain, jaundice, dark urine)
- Blood disorders — unusual bruising or bleeding, persistent sore throat or fever
- Severe skin reactions — Stevens-Johnson syndrome (rare)
Dependence & Withdrawal
Butalbital carries a significant risk of psychological and physical dependence, especially with prolonged or frequent use. Withdrawal from butalbital can be life-threatening and should always be managed under medical supervision.
- Dependence risk: Physical dependence can develop even at recommended doses when used regularly over time. Psychological dependence may also occur.
- Tolerance: Patients may require increasing doses to achieve the same effect, increasing the risk of adverse effects.
- Withdrawal symptoms: Abrupt discontinuation after regular use can cause anxiety, insomnia, tremors, seizures, and potentially death.
- Tapering: Gradual dose reduction under medical supervision is essential for patients who have used butalbital regularly.
- Medication overuse headache: Frequent use (more than 10 days per month) can lead to chronic daily headache.
Patients with a history of substance use disorder have an increased risk of misuse and dependence. Butalbital should be used with extreme caution in this population.
Drug Interactions
Major Interactions (Avoid or Use Extreme Caution)
- Opioids — concurrent use can cause profound sedation, respiratory depression, coma, and death
- Other CNS depressants (benzodiazepines, alcohol, antihistamines, sleep medications) — additive sedation and respiratory depression
- MAO inhibitors — may potentiate the effects of butalbital
Moderate Interactions (Monitor Closely)
- CYP enzyme inducers (rifampin, carbamazepine, phenytoin, St. John's Wort) — may decrease butalbital effectiveness
- CYP enzyme inhibitors — may increase butalbital levels
- Other acetaminophen-containing products — risk of exceeding maximum acetaminophen dose
- Oral anticoagulants (warfarin) — acetaminophen may enhance anticoagulant effect
Precautions & Warnings
- Pregnancy: Butalbital is FDA Pregnancy Category C. Use during pregnancy only if benefits outweigh risks. May cause neonatal withdrawal symptoms.
- Breastfeeding: Butalbital is excreted in breast milk. Use is generally not recommended due to potential sedation in nursing infants.
- Liver disease: Use with caution; butalbital is metabolized by the liver. Acetaminophen component poses additional liver risk.
- Kidney disease: Use with caution; dose adjustment may be needed.
- History of substance use disorder: Increased risk of misuse and dependence. Use with extreme caution and close monitoring.
- Porphyria: Butalbital may precipitate acute attacks.
- Elderly patients: Increased sensitivity; start at lower doses. Higher risk of falls, fractures, and cognitive impairment.
- Driving and machinery: Butalbital causes drowsiness and impairs coordination. Do not drive or operate heavy machinery.
When to Contact a Clinician
Reach out to your healthcare provider if you experience any of the following:
- Your headaches are becoming more frequent (more than 10 headache days per month)
- You feel you need to take more medication to achieve the same effect (tolerance)
- You are having difficulty functioning at work or home due to sedation
- You notice new or unexpected side effects
- You are experiencing mood changes, depression, or thoughts of self-harm
- You are pregnant or planning to become pregnant
- You have questions about how long you should take this medication
- You want to stop the medication — consult your provider for guidance
Seek emergency care immediately if you experience severe allergic reaction, difficulty breathing, signs of liver damage, or severe drowsiness.
Further Reading
- DailyMed — Butalbital Label (National Library of Medicine)
- MedlinePlus — Butalbital (National Library of Medicine)
- PubChem — Butalbital (National Institutes of Health)
- StatPearls — Medication Overuse Headache (National Library of Medicine)